Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...
IOC President Kirsty Coventry is ready to bring back the genetic tests that had been abandoned for over 30 years, and also ...
Kerala faces a third year of high leptospirosis deaths. Learn about the spread, prevention, and urgent need for timely ...
For the first time, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting COVID-19, the ...
Amoebic meningoencephalitis caused more deaths than flu (influenza) and rabies in the state in 2025. The health department ...
Tempus AI, Inc. (NASDAQ:TEM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 22, 2025, that ...
Through December 10, the world has seen 502,264 chikungunya cases worldwide, with 291,451 in the Americas region alone ...
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted ...
India’s economy crossing the $4.18 trillion mark and moving ahead of Japan in nominal GDP terms is a major headline moment.
TipRanks on MSN
2 new IPO stocks enter the fray; JP Morgan says 'buy'
In this past year, we’ve seen the IPO market stabilize after several years of large-scale uncertainties – think post-COVID ...
Co-Diagnostics (CODX) announced that it has filed a Certificate of Amendment to its Certificate of Incorporation to effect a reverse stock split of its common stock at a ratio of 1-for-30 shares. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback